Dose-dependent inhibition of the post-prandial glycaemic response to a standard carbohydrate meal following incorporation of alpha-cyclodextrin

Annals of Nutrition and Metabolism

Volumn 50, Issue 2, 2006, Pages 108-114

  Buckley, Jonathan D ^a   Thorp, Alicia A ^a   Murphy, Karen J ^a   Howe, Peter R C ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Cyclodextrin; Glucose; Glycaemic index; Insulin; Palatability; Satiety

Indexed keywords

ALPHA CYCLODEXTRIN; CARBOHYDRATE; CAVAMAX; GLUCOSE; INSULIN; OLIGOSACCHARIDE;

ABDOMINAL CRAMP; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOATING; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIGESTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FOOD INTAKE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; MALE; MEAL; NAUSEA; NORMAL HUMAN; PALATABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RICE; SATIETY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; STOMACH PAIN; TIME;

EID: 84988248537     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090498     Document Type: Article

References (26)

1. Augustin L, Galeone C, Dal Maso L, Pelucchi C, Ramazzotti V, Jenkins D, Montella M, Talamini R, Negri E, Franceschi S, La Vecchia C: Glycemic index, glycemic load and risk of prostate cancer. Int J Cancer 2004;112:446-450.
2. Dickinson S, Brand-Miller J: Glycemic index, postprandial glycemia and cardiovascular disease. Curr Opin Lipidol 2005;16:69-75.
3. Gerich J: Clinical significance, pathogenesis, and management of postprandial hyperglycemia. Arch Intern Med 2003;163:1306-1316.
4. Hodge A, English D, O'Dea K, Giles G: Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004;27:2701-2706.
5. Silvera S, Jain M, Howe G, Miller A, Rohan T: Dietary carbohydrates and breast cancer risk: a prospective study of the roles of overall glycemic index and glycemic load. Int J Cancer 2004;17:DOI:10.1002/ijc.20796.
6. Brand-Miller J: Glycemic load and chronic disease. Nutr Rev 2003;61:S49-S55.
7. Frost G, Leeds A, Trew G, Margara R, Dornhorst A: Insulin sensitivity in women at risk of coronary heart disease and the effect of a low glycemic diet. Metabolism 1998;47:1245-1251.
8. Opperman A, Venter C, Oosthuizen W, Thompson R, Vorster H: Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004;92:367-381.
9. Rizkalla S, Bellisle F, Slama G: Health benefits of low glycaemic index foods, such as pulses, in diabetic patients and healthy individuals. Br J Nutr 2002;88:S255-S262.
10. Roberts S, Pittas A: The role of glycemic index in type 2 diabetes. Nutr Clin Care 2003;6:73-78.
11. Brand-Miller JC, Holt SH, Pawlak DB, McMillan J: Glycemic index and obesity. Am J Clin Nutr 2002;76:S281-S285.
12. Ludwig D: Dietary glycemic index and the regulation of body weight. Lipids 2003;38:117-121.
13. Pawlak D, Kushner J, Ludwig D: Effects of dietary glycaemic index on adiposity, glucose homeostasis, and plasma lipids in animals. Lancet 2004;364:778-785.
14. Biwer A, Antranikian G, Heinzle E: Enzymatic production of cyclodextrins. Appl Microbiol Biotechnol 2002;59:609-617.
15. Szejtli J: Chemistry, physical and biological properties of cyclodextrins; in Atwoods J, Lehm J-M (eds): Comprehensive Supramolecular Chemistry. Oxford, Pergamon, 1996, pp 5-40.
16. 14C-a- cyclodextrin in germ-free and conventional rats. Regul Toxicol Pharmacol 2004;39:S57-S66.
17. Andersen G, Robbins F, Domingues F, Moores R, Long C: The utilization of Schardinger dextrins by the rat. Toxicol Appl Pharmacol 1963;5:257-266.
18. Koukiekolo R, Desseaux V, Moreau Y, Marchis-Mouren G, Santimone M: Mechanism of porcine pancreatic a-amylase. Inhibition of amylose and maltopentaose hydrolysis by a-, β- and γ-cyclodextrins. Eur J Biochem 2001;268:841-848.
19. Móra S, Simon I, Elödi P: Studies on the active center of pancreatic amylase. I. Binding of β-cyclodextrin. Mol Cell Biochem 1974;4:205-209.
20. Raben A, Andersen K, Karberg M, Holst J, Astrup A: Acetylation of or beta-cyclodextrin addition to potato starch: beneficial effect on glucose metabolism and appetite sensations. Am J Clin Nutr 1997;66:304-314.
21. Diamantis I, Bär A: Effect of a-Cyclodextrin on the Glycemic Index (GI) and Insulinemic Index (II) of Starch in Healthy Human Volunteers. Munich, Wacker Chemie, 2002.
22. World Health Organisation: Joint FAO/WHO Expert Committee on Food Additives, 63rd meeting. Geneva, WHO, 2004.
23. Food Standards Australia and New Zealand: Final Assessment Report. Application A494. Alpha-Cyclodextrin as a Novel Food. Melbourne, FSANZ, 2004.
24. Wolever T: Effect of blood sampling schedule and method of calculating the area under the curve on validity and precision of glycaemic index values. Br J Nutr 2004;91:295-300.
25. Read N: Small bowel transit time of food in man: measurement, regulation and possible importance. Scand J Gastroenterol 1984;96:77-85.
26. Anderson G, Woodend D: Effect of glycemic carbohydrates on short-term satiety and food intake. Nutr Rev 2003;61:S17-S26.